North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper on the Diagnosis and Management of Pediatric Acute Liver Failure
- PMID: 34347674
- DOI: 10.1097/MPG.0000000000003268
North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper on the Diagnosis and Management of Pediatric Acute Liver Failure
Abstract
Pediatric acute liver failure (PALF) is a rare, rapidly progressive clinical syndrome with significant morbidity and mortality. The phenotype of PALF manifests as abrupt onset liver dysfunction, which can be brought via disparate etiology. Management is reliant upon intensive clinical care and support, often provided by the collaborative efforts of hepatologists, critical care specialists, and liver transplant surgeons. The construction of an age-based diagnostic approach, the identification of a potential underlying cause, and the prompt implementation of appropriate therapy can be lifesaving; however, the dynamic and rapidly progressive nature of PALF also demands that diagnostic inquiries be paired with monitoring strategies for the recognition and treatment of common complications of PALF. Although liver transplantation can provide a potential life-saving therapeutic option, the ability to confidently determine the certainness that liver transplant is needed for an individual child has been hampered by a lack of adequately tested clinical decision support tools and accurate predictive models. Given the accelerated progress in understanding PALF, we will provide clinical guidance to pediatric gastroenterologists and other pediatric providers caring for children with PALF by presenting the most recent advances in diagnosis, management, pathophysiology, and associated outcomes.
Copyright © 2021 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
Conflict of interest statement
The authors report no conflicts of interest.
Comment in
-
Comment on the "NASPGHAN Position Paper on the Diagnosis and Management of Pediatric Acute Liver Failure".J Pediatr Gastroenterol Nutr. 2022 May 1;74(5):e130. doi: 10.1097/MPG.0000000000003408. J Pediatr Gastroenterol Nutr. 2022. PMID: 35149645 No abstract available.
-
Response to: Comment on the "NASPGHAN Position Paper on the Diagnosis and Management of Pediatric Acute Liver Failure".J Pediatr Gastroenterol Nutr. 2022 May 1;74(5):e130-e131. doi: 10.1097/MPG.0000000000003409. J Pediatr Gastroenterol Nutr. 2022. PMID: 35149646 No abstract available.
References
-
- Cockayne EA. Catarrhal jaundice, sporadic and epidemic, and its relation to acute yellow atrophy of the liver. QJM 1912; 6:1–29.
-
- Jay V. The legacy of Karl Rokitansky. Arch Pathol Lab Med 2000; 124:345–346.
-
- Kahn M, Barsky J. Acute yellow atrophy of the liver. Arch Intern Med 1921; 28:9.
-
- JAMA E. Acute yellow atrophy of the liver. JAMA 1947; 133:2.
-
- Rodgers JB, Mallory GK, Davidson CS. Massive liver cell necrosis. Archives of Internal Medicine 1964; 114:9.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical